Arcutis Biotherapeutics, Inc. SEC filings ARQT
Arcutis Biotherapeutics, Inc. has 866 filings in SEC EDGAR's recent list, going back to Sep 9, 2019. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Apr 21, 2026. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Nov 4, 2026 | — |
| S-8 | Employee stock plan registration | Apr 21, 2026 | — |
| S-8 | Employee stock plan registration | Feb 25, 2026 | — |
| S-3ASR | Automatic shelf registration | Feb 25, 2026 | — |
| S-8 | Employee stock plan registration | Feb 25, 2025 | — |
| 424B5 | Prospectus supplement | Mar 1, 2024 | — |
| 424B5 | Prospectus supplement | Feb 28, 2024 | — |
| S-8 | Employee stock plan registration | Feb 27, 2024 | — |
| 424B5 | Prospectus supplement | Feb 8, 2024 | — |
| S-3 | Shelf registration | Jan 31, 2024 | — |
| 424B5 | Prospectus supplement | Oct 23, 2023 | — |
| 424B5 | Prospectus supplement | Oct 19, 2023 | — |
| S-8 | Employee stock plan registration | Feb 28, 2023 | — |
| 424B5 | Prospectus supplement | Aug 4, 2022 | — |
| 424B5 | Prospectus supplement | Aug 2, 2022 | — |
| S-8 | Employee stock plan registration | Feb 22, 2022 | — |
| 424B5 | Prospectus supplement | May 6, 2021 | — |
| S-8 | Employee stock plan registration | Feb 16, 2021 | — |
| 424B5 | Prospectus supplement | Feb 4, 2021 | — |
| 424B5 | Prospectus supplement | Feb 1, 2021 | — |
| S-3ASR | Automatic shelf registration | Feb 1, 2021 | — |
| 424B4 | Prospectus | Oct 5, 2020 | — |
| S-1 | Registration statement | Sep 29, 2020 | — |
| 424B4 | Prospectus | Jan 31, 2020 | — |
| S-8 | Employee stock plan registration | Jan 31, 2020 | — |
| S-1MEF | Filing | Jan 30, 2020 | — |
| S-1/A | Amended registration statement | Jan 21, 2020 | — |
| S-1 | Registration statement | Jan 6, 2020 | — |
Showing 28 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ARQT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Westlake Village, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1787306
- Former names
- Arcutis, Inc. (until Sep 9, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.